Fapon Biopharma, a biotech innovator in developing therapeutic antibodies and fusion proteins, is pleased to announce that the U.S. Food and Drug ...

Republican Texas Sen. Ted Cruz and Rep. Chip Roy reintroduced legislation Wednesday to cut red tape preventing Americans from ...

Incyte today announced that multiple abstracts featuring new data from its dermatology portfolio will be presented at the 2025 American Academy of Dermatology (AAD) Annual Meeting, being held March 7?

GenBio AI, a leading company at the intersection of AI and biology, is excited to announce that Dr. Ziv Bar-Joseph has joined as Co-founder and Chief Scientific ...

Reported $781.4 million in full year 2024 revenues, representing 97% year-over-year growthSYFOVRE® (pegcetacoplan injection) full year 2024 net ...

Innovative copper oxide nanoparticles developed for medical devices show antimicrobial properties, potentially reducing ...

Antimicrobial nanoparticles are designed to combat bacterial resistance through mechanisms like ROS generation, membrane ...

We remain committed to bringing an ophthalmic bevacizumab to market in the United States and providing retina patients suffering from wet AMD with a much needed treatment option that has the potential ...

Understand the significant growth trajectory of the Kidney segment, which is expected to reach US$1.6 Billion by 2030 with a ...

It said NAFDAC had directed all zonal directors and state coordinators to carry out surveillance activities and remove all ...

Covid-19 showed us how vulnerable the world is to pandemics – but what if the next pandemic were somehow engineered? How would the world respond – and could we stop it happening in the first place?

EpiVax, Inc. proudly announces the appointment of Guilhem Richard as Chief Technology Officer. Dr. Richard joined EpiVax's immunoinformatics team in 2014 and spearheaded the development of a new ...